Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons

被引:139
作者
Cheng, NN
Maeda, T
Kume, T
Kaneko, S
Kochiyama, H
Akaike, A
Goshima, Y
Misu, Y
机构
[1] KYOTO UNIV, FAC PHARMACEUT SCI, DEPT PHARMACOL, SAKYO KU, KYOTO 60601, JAPAN
[2] YOKOHAMA CITY UNIV, SCH MED, DEPT PHARMACOL, YOKOHAMA, KANAGAWA 236, JAPAN
关键词
ascorbic acid; autoxidation; dopamine; glutamate; L-DOPA; neurotoxicity; striatum;
D O I
10.1016/S0006-8993(96)01056-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The neurotoxicity of L-DOPA and dopamine (DA) on striatal neurons was examined by using primary cultures of rat striatum. Exposure to L-DOPA and DA at concentrations of 30-300 mu M induced dose-dependent cell death in both younger cultures (3 days in culture, 3 DIC) and elder cultures (10 days in culture, 10 DIC). The cytotoxicity of L-DOPA and DA was also dependent on the exposure time (6-24 h). Ascorbic acid (200 mu M) inhibited both L-DOPA- and DA-induced cytotoxicity in 3 DIC cultures, whereas it provided significant protection against DA- but not L-DOPA-induced cytotoxicity in 10 DIC cultures. The L-DOPA cytotoxicity in 10 DIC cultures was prevented by a non-NMDA receptor antagonist, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), and by an NMDA receptor antagonist, MK-801. Neither antagonist prevented DA cytotoxicity. D-DOPA did not affect the viability of 10 DIC cultures, though it elicited marked toxicity in 3 DIC cultures. These results suggest that there are two components in the mechanisms that mediate the L-DOPA neurotoxicity on striatal neurons: one is autoxidation-relevant and the other is autoxidation-irrelevant. With respect to the latter, glutamate receptor stimulation may be involved. In contrast, autoxidation plays an important role in DA neurotoxicity.
引用
收藏
页码:278 / 283
页数:6
相关论文
共 30 条
[1]   CHANGES IN EXTRACELLULAR LEVELS OF GLUTAMATE AND ASPARTATE IN RAT SUBSTANTIA-NIGRA INDUCED BY DOPAMINE-RECEPTOR LIGANDS - IN-VIVO MICRODIALYSIS STUDIES [J].
ABARCA, J ;
GYSLING, K ;
ROTH, RH ;
BUSTOS, G .
NEUROCHEMICAL RESEARCH, 1995, 20 (02) :159-169
[2]   CHOLECYSTOKININ-INDUCED PROTECTION OF CULTURED CORTICAL-NEURONS AGAINST GLUTAMATE NEUROTOXICITY [J].
AKAIKE, A ;
TAMURA, Y ;
SATO, Y ;
OZAKI, K ;
MATSUOKA, R ;
MIURA, S ;
YOSHINAGA, T .
BRAIN RESEARCH, 1991, 557 (1-2) :303-307
[3]   DOPAMINE-INDUCED PROTECTION OF STRIATAL NEURONS AGAINST KAINATE RECEPTOR-MEDIATED GLUTAMATE CYTOTOXICITY IN-VITRO [J].
AMANO, T ;
UJIHARA, H ;
MATSUBAYASHI, H ;
SASA, M ;
YOKOTA, T ;
TAMURA, Y ;
AKAIKE, A .
BRAIN RESEARCH, 1994, 655 (1-2) :61-69
[4]  
BASMA AN, 1995, J NEUROCHEM, V64, P825
[5]   DOPAMINE NEUROTOXICITY - INHIBITION OF MITOCHONDRIAL RESPIRATION [J].
BENSHACHAR, D ;
ZUK, R ;
GLINKA, Y .
JOURNAL OF NEUROCHEMISTRY, 1995, 64 (02) :718-723
[6]   DOES LEVODOPA AGGRAVATE PARKINSONS-DISEASE [J].
BLIN, J ;
BONNET, AM ;
AGID, Y .
NEUROLOGY, 1988, 38 (09) :1410-1416
[7]  
COHEN G, 1974, J BIOL CHEM, V249, P2447
[8]   INHIBITORY EFFECTS OF NORADRENALINE AND DOPAMINE ON CALCIUM INFLUX AND NEUROTRANSMITTER GLUTAMATE RELEASE IN MAMMALIAN BRAIN-SLICES [J].
CROWDER, JM ;
BRADFORD, HF .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 143 (03) :343-352
[9]   BASAL LIPID-PEROXIDATION IN SUBSTANTIA NIGRA IS INCREASED IN PARKINSONS-DISEASE [J].
DEXTER, DT ;
CARTER, CJ ;
WELLS, FR ;
JAVOYAGID, F ;
AGID, Y ;
LEES, A ;
JENNER, P ;
MARSDEN, CD .
JOURNAL OF NEUROCHEMISTRY, 1989, 52 (02) :381-389
[10]   SHOULD LEVODOPA THERAPY FOR PARKINSONISM BE STARTED EARLY OR LATE - EVIDENCE AGAINST EARLY TREATMENT [J].
FAHN, S ;
BRESSMAN, SB .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1984, 11 (01) :200-205